BioSpace News Archive

Exact Sciences Corp. announced that company management will participate in the following virtual conferences and invited investors to participate by webcast.

Analyses of long-term study with Givinostat in Duchenne Muscular Dystrophy boys continue to show delayed disease progression

MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company focused on next-generation bio-therapeutic solutions for tissue repair and regeneration, today announced the initiation of a new clinical development program to evaluate its drug product candidate MWPC005 in patients with non-melanoma skin cancer

VBL Therapeutics (Nasdaq: VBLT) today announced the results of the independent Data Safety Monitoring Committee (DSMC) pre-planned review of the ongoing OVAL Phase 3 registration enabling study of VB-111 in recurrent ovarian cancer.

Trevena, Inc. (TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that it will present a corporate update at the 10 th Annual SVB Leerink Global Healthcare Conference on Friday, February 26, 2021 at 8:40 a.m. EST.

Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat pulmonary disease, announces U.S. Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to commence its pivotal clinical trial called RheSolve,

U.S. Expansion Initiative Underway with Recruitment of Key U.S.-based Executives to Drive Clinical Translation of Its Programs; Anticipates Making U.S.-based Board Appointments in the near-term as PYC Establishes Itself as the Global Leader in Ocular RNA Therapeutics

Brainlab announced today that the company has reached two major milestones with the FDA clearance for both Loop-X ® Mobile Imaging Robot and Cirq ® , a robotic surgical system. Following on CE mark approvals last summer, the FDA clearance paves the way for Brainlab to now enter the US markets with the Cirq robotic alignment module for spine procedures, and Loop-X

Hope Biosciences Stem Cell Research Foundation, administered through the Greater Houston Community Foundation, was founded to address the need to accelerate translational research in regenerative medicine so that therapies could be delivered to patients faster.

Nephros , Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its fourth quarter and full year 2020 financial results on Monday, March 1, 2021 after market close and will host a conference call that same day at 4:30 PM ET